ArticleJournal of clinical medicine2020

Assessment of Minimal Residual Disease by Next Generation Sequencing in Peripheral Blood as a Complementary Tool for Personalized Transplant Monitoring in Myeloid Neoplasms.

Paula Aguirre-Ruiz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.